相关实验视频
Updated: Mar 12, 2026

07:32
Assessment of Vascular Regeneration in the CNS Using the Mouse Retina
Published on: June 23, 2014
14.9K
[Neovasculgen® - 它的有效性已经被证明了吗? (Audiatur et altera pars) ] (听众和其他部分)
A N Vachev1, V V Bazylev2, A V Troitskiy3
1Department and Clinic of Faculty Surgery, Samara State Medical University, Ministry of Health of the Russian Federation, 443099, Samara, Russian Federation.
概括
目前对Neovasculgen®在治疗由于动脉样硬化导致的慢性下肢缺血的证据不足. 在国家临床指南中推它之前,需要更多的研究.
科学领域:
- 血管医学 血管医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性下肢缺血症 (CLI) 是由动脉样硬化引起的严重疾病.
- Neovasculgen®是一种注册药物,在CLI中被调查其潜在的治疗效果.
研究的目的:
- 评估Neovasculgen®在CLI患者中疗效的现有证据基础.
- 确定当前的数据是否支持将Neovasculgen®纳入国家临床指南.
主要方法:
- 对Neovasculgen®的现有研究进行系统审查.
- 关于Neovasculgen®对动脉样硬化病变和CLI进展的影响的证据分析.
主要成果:
- 目前支持Neovasculgen®对CLI的积极影响的证据基础被认为是不足的.
- 该药物在主血管动脉样硬化病变的管理中的有效性在这个阶段仍然是不确定的.
结论:
- 由于证据不足,不建议将Neovasculgen®纳入国家临床指南.
- 需要进一步的研究来确定Neovasculgen®在CLI治疗中的最终益处和作用.
相关概念视频
Vascular Resistance
12.3K
Vascular resistance is a critical concept in understanding blood flow dynamics in the circulatory system. It refers to the resistance that blood encounters as it flows through the blood vessels. This resistance is a key factor in determining blood pressure and cardiac workload.
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
12.3K
Antihypertensive Drugs: Vasodilators
2.4K
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.4K
Dose-Response Relationship: Potency and Efficacy
7.1K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
7.1K
Regulation of Angiogenesis and Blood Supply
3.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
573
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
573
Cardiac Output II: Effect of Stroke Volume on Cardiac Output
4.0K
Cardiac output (CO), the amount of blood the heart pumps per minute, is a parameter in cardiovascular physiology determined by stroke volume and heart rate. Stroke volume, the amount of blood pushed from one of the ventricles per heartbeat, is influenced by preload, afterload, and contractility.
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
4.0K

